WellRX, the parent company of preventative healthcare brands ReviveRX and Ways2Well, announced it acquired Bioreach, a bloodwork and genetics laboratory company. This deal brings advanced blood testing capabilities in-house, streamlining diagnostics and enabling the delivery of innovative health tests across WellRX’s ecosystem, such as partner telehealth clinics, weight-loss programs, testosterone therapies, and regenerative medicine services.
This strategic move expands WellRX’s commitment to offering a vertically integrated approach to patients seeking to optimize their overall health and wellness.
Bioreach will support clinics by enhancing patient outcomes through data-driven health solutions. Telehealth providers who often rely on ReviveRX for prescription services will now benefit from seamless bloodwork integration, providing comprehensive care to their patients. This advancement expands testing services offered by Ways2Well, WellRX’s telehealth clinic specializing in preventative care and functional medicine, bringing health insights to over 50,000 patients nationwide.
A single drop of blood can measure thousands of protein, fat, and metabolic molecules, helping detect metabolic and immune responses and pave the way for early disease detection and diagnosis (Stanford). Bloodwork results traditionally have taken five to seven business days to process. And with Bioreach’s 80% improvement in testing efficiency, WellRX will cut this to just one day—a significant improvement for patients and providers nationwide. Bioreach, ReviveRX, and Ways2Well will also continue bringing more tests to the market.
KEY QUOTES:
“Bioreach is a transformative addition for WellRX and its subsidiaries. By integrating Bioreach’s cutting-edge capabilities, we’re not only accelerating bloodwork turnaround times but also unlocking deeper insights into patient health through our pharmacy and telehealth partnerships. This acquisition empowers us to drive down costs, achieve seamless vertical integration, and deliver proactive, predictive care. Together, we are reshaping healthcare to focus on healthspan—and one day, even lifespan—offering unmatched innovation, efficiency, and value to patients, clinicians, and providers. The future of medicine starts here.”
– Brigham Buhler, Founder and CEO of WellRX
“Our team at Bioreach has done a tremendous job educating Utah’s population on what various biomarkers in their blood can tell them about their health, so they may work in tandem with a medical professional to create a personalized wellness plan. By joining WellRX, we’re positioned to scale affordable, high-quality blood testing services across the country. We see a bright future with expanding our impact, particularly as we integrate with ReviveRX’s patient-centric pharmacy services and Ways2Well’s innovative telehealth care.”
– Jack Matsen, CEO of Bioreach
